BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 21860817)

  • 1. Irritable bowel syndrome, gut microbiota and probiotics.
    Lee BJ; Bak YT
    J Neurogastroenterol Motil; 2011 Jul; 17(3):252-66. PubMed ID: 21860817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
    Harris LA; Baffy N
    Postgrad Med; 2017 Nov; 129(8):872-888. PubMed ID: 28936910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and irritable bowel syndrome.
    Dai C; Zheng CQ; Jiang M; Ma XY; Jiang LJ
    World J Gastroenterol; 2013 Sep; 19(36):5973-80. PubMed ID: 24106397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.
    Lee KN; Lee OY
    World J Gastroenterol; 2014 Jul; 20(27):8886-97. PubMed ID: 25083061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Gut-Microbiota in the Pathophysiology and Therapy of Irritable Bowel Syndrome: A Systematic Review.
    Shrestha B; Patel D; Shah H; Hanna KS; Kaur H; Alazzeh MS; Thandavaram A; Channar A; Purohit A; Venugopal S
    Cureus; 2022 Aug; 14(8):e28064. PubMed ID: 36127988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the ties between irritable bowel syndrome and intestinal microbiota.
    Hong SN; Rhee PL
    World J Gastroenterol; 2014 Mar; 20(10):2470-81. PubMed ID: 24627584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of commensals and probiotics on visceral sensitivity and pain in irritable bowel syndrome.
    Theodorou V; Ait Belgnaoui A; Agostini S; Eutamene H
    Gut Microbes; 2014; 5(3):430-6. PubMed ID: 25184834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome.
    Singh P; Lembo A
    Gastroenterol Clin North Am; 2021 Sep; 50(3):523-545. PubMed ID: 34304786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constipation-Predominant Irritable Bowel Syndrome (IBS-C): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms.
    Di Rosa C; Altomare A; Terrigno V; Carbone F; Tack J; Cicala M; Guarino MPL
    Nutrients; 2023 Mar; 15(7):. PubMed ID: 37049488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Short Chain Fatty Acids in Irritable Bowel Syndrome.
    Jiang W; Wu J; Zhu S; Xin L; Yu C; Shen Z
    J Neurogastroenterol Motil; 2022 Oct; 28(4):540-548. PubMed ID: 36250361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets.
    Dupont HL
    Aliment Pharmacol Ther; 2014 May; 39(10):1033-42. PubMed ID: 24665829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics, gut microbiota, and irritable bowel syndrome: What are the relations?
    Mamieva Z; Poluektova E; Svistushkin V; Sobolev V; Shifrin O; Guarner F; Ivashkin V
    World J Gastroenterol; 2022 Mar; 28(12):1204-1219. PubMed ID: 35431513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Irritable Bowel Syndrome, Emotion Regulation, and Gut Microbiota].
    Fukudo S
    Brain Nerve; 2016 Jun; 68(6):607-15. PubMed ID: 27279158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gut microbiome and irritable bowel syndrome: State of art review.
    Salem AE; Singh R; Ayoub YK; Khairy AM; Mullin GE
    Arab J Gastroenterol; 2018 Sep; 19(3):136-141. PubMed ID: 29935865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota-host interactions in irritable bowel syndrome: epithelial barrier, immune regulation and brain-gut interactions.
    Hyland NP; Quigley EM; Brint E
    World J Gastroenterol; 2014 Jul; 20(27):8859-66. PubMed ID: 25083059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid-gut microbiota crosstalk in irritable bowel syndrome.
    Gu Y; Li L; Yang M; Liu T; Song X; Qin X; Xu X; Liu J; Wang B; Cao H
    Crit Rev Microbiol; 2023 May; 49(3):350-369. PubMed ID: 35389754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota-Based Therapies for Irritable Bowel Syndrome.
    Stern EK; Brenner DM
    Clin Transl Gastroenterol; 2018 Feb; 9(2):e134. PubMed ID: 29446765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the gut microbiota for the treatment of irritable bowel syndrome.
    Herndon CC; Wang YP; Lu CL
    Kaohsiung J Med Sci; 2020 Mar; 36(3):160-170. PubMed ID: 31782606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.
    Chey WD; Maneerattaporn M; Saad R
    Gut Liver; 2011 Sep; 5(3):253-66. PubMed ID: 21927652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irritable Bowel Syndrome; gut microbiota and probiotic therapy].
    Tojo González R; Suarez Gonzalez A; Rúas Madiedo P; Mancebo Mata A; Pipa Muñiz M; Barreiro Alonso E; Roman Llorente FJ; Moro Villar MC; Arce González MM; Villegas Diaz MF; Mosquera Sierra E; Ruiz Ruiz M
    Nutr Hosp; 2015 Feb; 31 Suppl 1():83-8. PubMed ID: 25659060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.